KAUST researchers developed a new algorithm for detecting cause and effect in large datasets. The algorithm aims to find underlying models that generate data, helping uncover cause-and-effect dynamics. It could aid researchers across fields like cell biology and genetics by answering questions that typical machine learning cannot. Why it matters: This advancement could equip current machine learning methods with abilities to better deal with abstraction, inference, and concepts such as cause and effect.
MBZUAI researchers introduced CausalVerse, a new benchmark for causal representation learning (CRL) presented at NeurIPS 2025. CausalVerse combines high-fidelity visual complexity with access to underlying causal variables and graphs, featuring 200,000 images and 300 million video frames across 24 sub-scenes in four domains. It aims to provide a realistic and precise testbed to evaluate whether CRL methods can truly learn the right causes. Why it matters: By bridging the gap between toy datasets and real-world data, CausalVerse can drive advances in AI systems capable of understanding causality in complex scenarios.
Researchers from MBZUAI presented a new algorithm at ICLR 2024 that identifies causal relationships involving both observed and latent variables. The algorithm addresses limitations of existing methods that struggle with latent variables or assume observed variables don't directly influence latent variables. The proposed algorithm can accommodate both scenarios, offering a more generalizable approach to causal discovery. Why it matters: This research advances the development of AI systems that can analyze complex data and identify causal relationships, with potential applications in fields like medicine where understanding causality is crucial for developing treatments and preventative measures.
This article discusses a talk by Mingming Gong from the University of Melbourne at MBZUAI on bridging causality and machine learning. The talk focuses on using machine learning to discover causal structures from observational data, and leveraging causal structures to improve machine learning generalization and prediction in non-stationary environments. Gong's research explores theoretical foundations and computational innovations in causal structure learning from real-world data. Why it matters: This research direction is crucial for advancing AI systems that can reason about cause and effect, leading to more robust and reliable decision-making in complex environments.
MBZUAI researchers presented a study at ICML 2024 examining how data aggregation distorts causal discovery. The study argues that current methods are misled because real-world interactions happen at a micro level while observations are aggregated. Using the example of ice cream sales and temperature, they highlight how aggregation introduces "instantaneous causality" where time-lags exist. Why it matters: The research identifies a fundamental limitation in current causal discovery methods, potentially impacting disciplines relying on accurate causal inference from observational data.
MBZUAI Professor Kun Zhang is working on applying AI to understand cause-and-effect relationships in biology, with the goal of accelerating scientific discovery and improving human health. He aims to develop foundation models for biology that can process diverse data types and provide insights into the causes and treatments of health problems. These models could help scientists develop new medicines and preventative measures for diseases. Why it matters: This research has the potential to significantly advance the field of medicine by enabling a deeper understanding of the complex biological processes that underlie disease.
MBZUAI's Kun Zhang is applying causal machine learning to improve drug development and precision medicine, focusing on answering 'why' questions. Traditional drug development is costly (est. $2B) due to extensive studies needed to determine drug toxicity and efficacy. Zhang is combining causal ML with organs-on-chips technology to improve pre-clinical drug testing, aiming to reduce the failure rate of drugs in human trials. Why it matters: By improving the accuracy of pre-clinical drug testing, this research could significantly reduce the cost and time required to bring new medicines to market in the region and worldwide.
MBZUAI faculty Kun Zhang is researching methods to improve the reliability of generative AI, particularly in healthcare applications. Current generative AI models often act as "black boxes," making it difficult to understand why a specific result was produced. Zhang's research focuses on incorporating causal relationships into AI systems to ensure more accurate and meaningful information. Why it matters: Improving the trustworthiness of generative AI is crucial for sensitive sectors like healthcare and ensuring responsible AI deployment across the region.